These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 33894919
1. Hyperkalemia in a Patient With Leukemia. Su YJ, Huang CC, Hsieh CY, Hung YS, Chan MJ. Am J Kidney Dis; 2021 May; 77(5):A13-A14. PubMed ID: 33894919 [No Abstract] [Full Text] [Related]
2. Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia. Matsue K, Aoki T, Odawara J, Kimura S, Yamakura M, Takeuchi M. Leuk Res; 2009 Jun; 33(6):867-9. PubMed ID: 18951628 [No Abstract] [Full Text] [Related]
3. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Ronan Swords. Swords R. Drugs; 2007 Jun; 67(17):2655-6. PubMed ID: 18034599 [No Abstract] [Full Text] [Related]
4. Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment. Mustafa Ali MK, Sabha MM, Al-Rabi KH. Platelets; 2015 Jun; 26(5):491-4. PubMed ID: 25025538 [Abstract] [Full Text] [Related]
5. Hyperthyroidism associated with Philadelphia-chromosome-positive acute lymphoblastic leukemia. Oka S, Yokote T, Hiraiwa T, Akioka T, Hara S, Kobayashi K, Hirata Y, Yamano T, Tanimoto K, Tsuji M, Hanafusa T. J Clin Oncol; 2006 Jul 20; 24(21):3500-2. PubMed ID: 16849768 [No Abstract] [Full Text] [Related]
6. Philadelphia chromosome-positive acute lymphoblastic leukemia with an e14a3 BCR-ABL1 fusion: The role of molecular monitoring. Crampe M, Langabeer SE, O'Brien D, Ryan E, Bacon CL. Hematol Oncol Stem Cell Ther; 2020 Sep 20; 13(3):166-167. PubMed ID: 31158331 [No Abstract] [Full Text] [Related]
15. Pseudohyperkalemia--is serum or whole blood a better specimen type than plasma? Lee HK, Brough TJ, Curtis MB, Polito FA, Yeo KT. Clin Chim Acta; 2008 Oct 20; 396(1-2):95-6. PubMed ID: 18638465 [No Abstract] [Full Text] [Related]
16. Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission. Cherrier-De Wilde S, Rack K, Vannuffel P, Delannoy A, Hagemeijer A. Leukemia; 2003 Oct 20; 17(10):2046-8. PubMed ID: 14513056 [No Abstract] [Full Text] [Related]
17. Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD? Aldoss I, Pullarkat V. Bone Marrow Transplant; 2019 Jan 20; 54(1):3-5. PubMed ID: 30446742 [No Abstract] [Full Text] [Related]
18. Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia. Ganzel C, Kharit M, Duksin C, Rowe JM. Haematologica; 2018 Oct 20; 103(10):e489-e490. PubMed ID: 29954929 [No Abstract] [Full Text] [Related]
19. Pseudohyperkalaemia with acute leukaemia: association with pneumatic tube transport of blood specimens. Ku AS, Chen RH, Law RL. Hong Kong Med J; 2014 Apr 20; 20(2):158-60. PubMed ID: 24714171 [Abstract] [Full Text] [Related]
20. Reverse pseudohyperkalemia in heparin plasma samples from a patient with chronic lymphocytic leukemia. Meng QH, Krahn J. Clin Biochem; 2011 Jun 20; 44(8-9):728-30. PubMed ID: 21406192 [Abstract] [Full Text] [Related] Page: [Next] [New Search]